Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
1993 | 1 |
1994 | 1 |
1997 | 1 |
1998 | 1 |
2000 | 1 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Non-specific antiviral activity of antisense molecules targeted to the E1 region of human papillomavirus.
Antiviral Res. 2000 Dec;48(3):187-96. doi: 10.1016/s0166-3542(00)00129-7.
Antiviral Res. 2000.
PMID: 11164505
Ro 32-3555, an orally active collagenase inhibitor, prevents cartilage breakdown in vitro and in vivo.
Lewis EJ, Bishop J, Bottomley KM, Bradshaw D, Brewster M, Broadhurst MJ, Brown PA, Budd JM, Elliott L, Greenham AK, Johnson WH, Nixon JS, Rose F, Sutton B, Wilson K.
Lewis EJ, et al. Among authors: greenham ak.
Br J Pharmacol. 1997 Jun;121(3):540-6. doi: 10.1038/sj.bjp.0701150.
Br J Pharmacol. 1997.
PMID: 9179398
Free PMC article.
Item in Clipboard
Ro 32-3555, an orally active collagenase selective inhibitor, prevents structural damage in the STR/ORT mouse model of osteoarthritis.
Brewster M, Lewis EJ, Wilson KL, Greenham AK, Bottomley KM.
Brewster M, et al. Among authors: greenham ak.
Arthritis Rheum. 1998 Sep;41(9):1639-44. doi: 10.1002/1529-0131(199809)41:9<1639::AID-ART15>3.0.CO;2-0.
Arthritis Rheum. 1998.
PMID: 9751097
Item in Clipboard
A novel in vivo model for the study of cartilage degradation.
Bishop J, Greenham AK, Lewis EJ.
Bishop J, et al. Among authors: greenham ak.
J Pharmacol Toxicol Methods. 1993 Sep;30(1):19-25. doi: 10.1016/1056-8719(93)90003-w.
J Pharmacol Toxicol Methods. 1993.
PMID: 8241542
Item in Clipboard
Ro 32-0432, a selective and orally active inhibitor of protein kinase C prevents T-cell activation.
Birchall AM, Bishop J, Bradshaw D, Cline A, Coffey J, Elliott LH, Gibson VM, Greenham A, Hallam TJ, Harris W, et al.
Birchall AM, et al. Among authors: greenham a.
J Pharmacol Exp Ther. 1994 Feb;268(2):922-9.
J Pharmacol Exp Ther. 1994.
PMID: 8114006
Item in Clipboard
Cite
Cite